Global Insulin Delivery Devices Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2017-2022 INSULIN DELIVERY DEVICES MARKET INSIGHTS: The Global Insulin Delivery Devices Market is expected to grow at the CAGR of 8.5% during 2017-2022. There are various pivotal factors that are boosting the market growth which includes rising incidence and prevalence rate of diabetes patients, increasing awareness among population towards the diabetes and a variety of insulin delivery devices and so forth. Insulin is a necessary element required for the treatment diabetes patients. Insulin enables a person’s body to use glucose from carbohydrates in the food consumed by the patient for future use. Insulin delivery is an approach used for delivering the insulin to a patient’s body through their fatty tissues. Rising diabetes patients are considered to be a key driver in the growth of global insulin delivery devices market. According to WHO, the number of people with diabetes has increased from 108 million in 1980 to 422 million in 2014. While, in 2015, approx 1.6 million deaths were reported due to diabetes. This significant increase in diabetes population and its effects have boosted the insulin delivery devices market significantly. Additionally, the government support and their reimbursement policies in some countries such as U.S are driving the market growth in a positive way. Federal government offers financial support to diabetes patients by providing them various health insurances. Medicare, the Children’s Health Insurance Program (CHIP), TRICARE, and veterans’ health care programs are some programs which supports patients. Moreover, some acts such as Affordable Care Act (ACA) prevents insurers from denying coverage or charging higher premiums to people with preexisting conditions, such as diabetes are also boosting the market considerably. The features of insulin delivery devices including its accuracy, efficiency and cost-effectiveness attract the customers from different regions and thus drive the market growth. There is a lack of reimbursement policies in some emerging economies such as Bulgaria; Czech Republic and so on which does not give so much priority to diabetes. In addition to policies, risk of infections associated with some devices such as insulin pens and syringes acts as a restraint for the market. The adoption of oral insulin as an alternative to these devices is negatively impacting the market. However, technological advancement and innovations to prevent this contamination and the significant rise in the amount of spending on diabetes are expected to create opportunities in the future. GEOGRAPHICAL INSIGHTS: Cohesive government policies and the high adoption of insulin delivery devices make North America a dominant region in the insulin delivery devices market. Additionally, high prevalence of diabetes and high diagnosis rate are some other factors that are driving the market North American market. APAC region is expected to be the fast growing region due to the more number of diabetes patients in the Asian countries such as China, India, Japan and so on. Moreover, rising awareness in APAC regions about diabetes and treatment are expected to boost the insulin delivery market. Competitive Insights: The key players which serve a major part of the diabetic population are Abbott Laboratories, Animas Corporation, Becton, Dickinson and Company, Biocon, ELI Lilly and Company, F. Hoffmann-La Roche, Ltd., Mannkind Corporation, Medtronic PLC Novo Nordisk A/S, Tandem Diabetes Care, Inc., Sanofi and SciGen and so on. Insulin Delivery Devices market companies are constantly focusing on product launch, R&D, partnerships, M&A, innovation and technological advancement. One such strategic partnership was done by Sanofi and AgaMatrix which both develop cutting-edge solutions in diabetes management. The report also includes detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, predictive analysis, pipeline analysis, market determinants, market segmentation, geographical analysis, company profiling of the market. MARKET SEGMENTATION: Global Insulin Delivery Devices Market can be bifurcated on the basis of device type, its distribution channel and its usage in end industries. The Reusable Insulin Pens are the most widely used device in the market. While, on the basis of end-users industry, the homecare applications holds the largest share of the market. Global Insulin Delivery Devices Market is segmented on the basis of three major categories which includes – Global Insulin Delivery Devices Market Research and Analysis, By Type Global Insulin Delivery Devices Market Research and Analysis, By Distribution Channel Global Insulin Delivery Devices Market Research and Analysis, By End-User Industry THE REPORT COVERS: Comprehensive research methodology of Global Insulin Delivery Devices Market. This report also includes detailed and extensive market overview with current market recommendations & key analysts insights. Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the Global Insulin Delivery Devices Market. Insights about market determinants which are stimulating the Global Insulin Delivery Devices Market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. CORPORATE OFFICE Orion Market Research Pvt Ltd 116, Shagun Arcade Indore, Madhya Pradesh India- 452010 Email: info@omrglobal.com Phone No. +91-731-4958007 Mobile No. +917803040404